Navigation Links
Interference Screws

ProductsInterference Screws
Company Atlantech Medical Devices Ltd.
Item Interference Screws
Features 
  • Titanium Construction
  • Available in a range of sizes
  • Description Our products, with carefully researched design features, are tailored to making arthroscopic and ligament reconstructive surgery more reproducible, easier, quicker and safer.
    Info Atlantech Medical Devices Ltd.
    Customer Service: +44 (0)1423 88 88 06
    Web site: http://www.atlantech-md.co.uk

    Related medicine products :

    1. PHANTOM Absorbable Cannulated Interference Screws
    2. PHANTOM SofThread Cannulated Interference Screws
    3. ADVANTAGE Titanium Cannulated Interference Screws
    4. PROFILE Titanium Cannulated Interference Screws
    5. ABSOLUTE Absorbable Cannulated Interference Screws
    6. BioScrew® Bio-Absorbable Interference Screws
    7. Propel Cannulated Interference Screw
    8. BIG ADVANTAGE Cannulated Titanium Interference Screws
    9. Guardsman Femoral Interference Screw
    10. Cannulated Interference Screws
    11. Gentle Threads Interference Screws
    ... OmniMD Medical Billing system allows a ... accounting. It is integrated with the ... The system interfaces with electronic clearinghouses ... With a set of reports, it ...
    ... CPNG3 single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... CPNG3 reagent provides a long shelf ...
    ... Infinity Uric Acid single liquid stable ... convenience of single liquid stability to ... error and provide quick result turnaround ... Infinity Uric Acid reagent provides a ...
    ... Oxidase single liquid stable reagent offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... Oxidase reagent provides a long shelf ...
    Medicine Products:
    (Date:7/1/2015)... ... July 01, 2015 , ... During the ... (Manager, National Sales Training and Development) and Chuck Corso (Associate Sales Trainer) participated ... Phoenix, AZ. LTEN brings together learning and development professionals from more than 300 ...
    (Date:7/1/2015)... Colorado) , ... - (PRWEB) July 01, 2015 , ... ... a nationwide virtual 5K on August 15-16th (MSG Keys’ birthday) in memory of her ... a highly decorated soldier and recipient of the Bronze Star Medal, died during a ...
    (Date:7/1/2015)... ... July 01, 2015 , ... “Well-meaning ... Lisa Stolzenberg, a Professor in FIU’s School of International and Public Affairs. ... years who participated in the National Survey on Drug Use and Health, which ...
    (Date:7/1/2015)... NJ (PRWEB) , ... July 01, 2015 , ... Scoliosis is a disorder in which ... National Scoliosis Foundation, it affects 2 to 3 percent of the population, or an estimated ... most often develops in children between the ages of 10 and 15. Most types of ...
    (Date:7/1/2015)... Sarasota, FL (PRWEB) , ... July 01, 2015 ... ... providers of premium delicatessen products, is helping families get ready for Independence Day ... to sweet sliders, these easy and versatile options are perfect for any summertime ...
    Breaking Medicine News(10 mins):Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 2Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 3Health News:Mission Pharmacal Company: Alamo Pharma Services' Training Leaders Take Steps to Further Expand Capabilities for Mission Pharmacal and Other Clients 4Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 2Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 3Health News:Scoliosis: A Guide for Parents from Orthopedic Surgeon Dr. Fabien Bitan 4Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3
    ... under a ,Pay or Play, law, 10,entry-level employees will ... new study presented as,part of a Cornell University symposium ... provide health insurance to their employees or a pay,fine, ... the work,force., The study sponsored by the Employment ...
    ... success in helping children , FRIDAY, Nov. 9 (HealthDay ... juvenile rheumatoid arthritis, according to studies presented this week ... Boston. , One study found that abatacept, used to ... be a well-tolerated treatment for children and adolescents with ...
    ... 24 and Taclonex; Company ... financial guidance, ST. DAVID,S, Bermuda, Nov. 9 Warner Chilcott,Limited ... ended,September 30, 2007. Revenue in the quarter ended September 30, 2007 ... The,primary drivers of the increase in revenue were the net sales ...
    ... Del., Nov. 9 AstraZeneca (NYSE:,AZN) announced today ... has,approved CRESTOR(R) (rosuvastatin calcium) as an adjunct to ... with elevated cholesterol.,This new indication gives CRESTOR an ... "This new indication allows us to share what ...
    ... RURAL HALL, N.C., EXTON, Pa. and SAN DIEGO, ... a southeastern US,provider of oncology equipment sales and ... strategic alliance with Radiology Oncology Systems, Inc.,(ROS), an ... and Acceletronics, Inc., a US provider of oncology ...
    ... 8 State,Compensation Insurance Fund is presenting a ... Fund,s Employer Education Series, featuring its own,innovative and ... seminar entitled "Watch Your Back",introduces an educational and ... the very people they are trying to protect ...
    Cached Medicine News:Health News:New Study: Health Insurance Mandates on Employers Hurt Low-Income Employees 2Health News:Drugs Can Ease Juvenile Rheumatoid Arthritis 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 2Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 3Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 4Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 5Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 6Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 7Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 8Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 9Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 10Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 11Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 12Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 13Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 14Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 15Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 16Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 17Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 18Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 19Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 20Health News:Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2007 21Health News:CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol 2Health News:CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol 3Health News:CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol 4Health News:RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US 2Health News:RS&A, Inc. Announces It Has Joined Radiology Oncology Systems, Inc. (ROS) and Acceletronics, Inc. in a Strategic Alliance to Better Serve Its Customers in the Southeastern US 3Health News:Free Seminar Features State Fund's Back Connection(TM), November 14, in Chico 2Health News:Free Seminar Features State Fund's Back Connection(TM), November 14, in Chico 3
    (Date:7/1/2015)... 2015 Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... inflammatory disease and neurologic disorders, announced today the results ... citrate, the Company,s lead compound. Results from the study ... can significantly inhibit the activation of inflammatory proteins in ... this compound in a Phase 1 clinical trial under ...
    (Date:7/1/2015)... , July 1, 2015  BioPharmX Corporation (NYSE MKT: ... underwritten public offering of 3,636,364 shares of its common ... per share. BioPharmX has granted the underwriters a 30-day ... common stock at the public offering price. ... an existing stockholder, has agreed to purchase 1,081,081 shares ...
    (Date:6/30/2015)... Scotland , July 1, 2015 ... joins Nu C ana team   ... ProTide technology to develop and commercialise a portfolio of ... Chris McGuigan as Chief Scientific Officer. ... ProTide technology. He is currently Professor of Medicinal Chemistry ...
    Breaking Medicine Technology:Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 2Internationally Renowned Medicinal Chemist Professor Chris McGuigan Appointed as NuCana's Chief Scientific Officer 3